Efficacy and Safety of Direct Oral Anticoagulants in Pediatric Venous Thromboembolism: A Systematic Review and Meta-Analysis

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Indian Journal of Pediatrics

• Publication date

  2023-12-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12098-023-04952-8PMID 38117441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct oral anticoagulants versus standard anticoagulation in children treated for acute venous thromboembolism

  2022cited by this paper
• Edoxaban for Thromboembolism Prevention in Pediatric Patients with Cardiac Disease.

  2022influential reference
• Dabigatran Etexilate for the Treatment of Acute Venous Thromboembolism in Children: Results of an Open-Label, Phase 2b/3, Randomised Clinical Trial

  2020influential reference
• Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.

  2020cited by this paper
• Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.

  2019cited by this paper
• Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.

  2019cited by this paper
• Are low-molecular-weight heparins safe and effective in children? A systematic review.

  2019cited by this paper
• Direct Oral Anticoagulants: Novel Approach for the Treatment of Thrombosis in Pediatric Patients?

  2019influential reference
• Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews

  2019cited by this paper
• Anticoagulant prophylaxis and therapy in children: current challenges and emerging issues

  2018influential reference
• Incidence Trends and Mortality from Childhood Venous Thromboembolism: A Population-Based Cohort Study.

  2016cited by this paper
• Safety, tolerability and clinical pharmacology of dabigatran etexilate in adolescents

  2016cited by this paper
• Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk-assessment models

  2015cited by this paper
• Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findings

  2015cited by this paper
• Hospital-associated venous thromboembolism in children: incidence and clinical characteristics.

  2014cited by this paper
• Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010influential reference
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Dramatic Increase in Venous Thromboembolism in Children's Hospitals in the United States From 2001 to 2007

  2009cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Developmental haemostasis

  2006cited by this paper
• Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome

  2003cited by this paper
• Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors.

  2001cited by this paper
• Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients.

  1999cited by this paper

• No citing papers are available for this paper.